AC090616.2 | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enhanced |
AC091150.1 | HCG1818186; Uncharacterized protein | | | | | | Not detected |
AC092675.3 | Uncharacterized protein | | | | | | Not detected |
AC093157.1 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC096644.1 | Uncharacterized protein | | | | | | Not detected |
AC104472.1 | CDNA FLJ26134 fis, clone TMS03713; Uncharacterized protein | | | | | | Not detected |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
AC110084.1 | | | | | | | Not detected |
AC112693.2 | | | | | | | Not detected |
AC114783.1 | Protein LOC339760 | Predicted secreted proteins
| | | | | Tissue enriched |
AC115618.1 | Uncharacterized protein; cDNA FLJ26048 fis, clone PRS02384 | | | | | | Tissue enhanced |
AC117834.1 | | | | | | | Tissue enhanced |
AC132186.1 | CDNA FLJ27243 fis, clone SYN08134; Uncharacterized protein | | | | | | Not detected |
AC132192.1 | LOC644656 protein; Uncharacterized protein | Predicted secreted proteins
| | | | | Mixed |
AC137056.1 | Uncharacterized protein; cDNA FLJ34659 fis, clone KIDNE2018863 | Predicted secreted proteins
| | | | | Group enriched |
AC140481.2 | Uncharacterized protein | | | | | | Tissue enriched |
AC144568.2 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC145205.1 | | | | | | | Not detected |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACADM | Acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACAN | Aggrecan | Predicted secreted proteins
| | | | | Mixed |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE | Angiotensin-converting enzyme; Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACP1 | Acid phosphatase 1, soluble | Enzymes Plasma proteins
| | | | | Expressed in all |
ACP2 | Acid phosphatase 2, lysosomal | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACP5 | Acid phosphatase 5, tartrate resistant | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ACP6 | Acid phosphatase 6, lysophosphatidic | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ACPL2 | Acid phosphatase-like 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACRV1 | Acrosomal vesicle protein 1 | Predicted secreted proteins
| | | | | Tissue enriched |
ACSF2 | Acyl-CoA synthetase family member 2 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACSF3 | Acyl-CoA synthetase family member 3 | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ACTN1 | Actinin, alpha 1 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
ACVR1 | Activin A receptor, type I | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACVRL1 | Activin A receptor type II-like 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ACYP1 | Acylphosphatase 1, erythrocyte (common) type | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ACYP2 | Acylphosphatase 2, muscle type | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM15 | ADAM metallopeptidase domain 15 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM18 | ADAM metallopeptidase domain 18 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM19 | ADAM metallopeptidase domain 19 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |